Can Tirzepatide Cause Diarrhoea — and What Can You Do About It?

How common is diarrhoea on tirzepatide, and why does it happen?

Diarrhoea appears in the list of common side effects in the tirzepatide SmPC, alongside nausea, vomiting, constipation and indigestion. The NHS tirzepatide page lists it as something that affects more than one in ten people, making it one of the most frequently reported complaints rather than a rare occurrence. That does not mean everyone experiences it, but it is common enough to be worth understanding before you begin.

The mechanism sits in tirzepatide's dual action on GIP and GLP-1 receptors. Both pathways slow the movement of food through the gut, and when gastric emptying changes pace, the digestive system can react unevenly. Contents that spend longer in the stomach may then move more quickly through the bowel, producing looser stools. The effect is physiological, not a sign the medicine is failing or harming you in itself. Our page on why tirzepatide causes diarrhoea covers the gut mechanism in more detail.

Dose matters too. Symptoms tend to be most pronounced at the 2.5mg starter dose as your system adapts, and can reappear briefly each time the dose steps up. Eating smaller meals, reducing high-fat or spicy food, and staying well hydrated all help most people get through the adjustment period without stopping treatment. If you started treatment before a long weekend or a holiday, factor in that the first week at each new dose is often the most unsettled.

Does tirzepatide always cause diarrhoea, or can it be avoided?

Not everyone experiences it. In the SURMOUNT-1 trial, a substantial proportion of participants in the tirzepatide groups reported GI side effects, but a meaningful share did not — and among those who did, many found symptoms reduced significantly once the body adjusted. Diarrhoea is listed as common rather than universal. Tirzepatide-related diarrhoea varies considerably between individuals; some people notice nothing beyond occasional loose stools, while others find the first fortnight genuinely disruptive.

Practical steps that can reduce the impact include eating slowly, avoiding large portions, cutting back on high-fat meals and keeping alcohol moderate. Some people find that timing injections mid-week (rather than on a Friday when they want to feel well for the weekend) helps them manage peak adjustment days more easily. These are not prescribing instructions; they are the kind of practical advice a prescriber or pharmacist can personalise for your situation. You can read about the broader Mounjaro side effects profile to put diarrhoea into context alongside nausea, constipation and other GI effects.

If symptoms are severe from the outset, your prescriber may consider holding at the current dose for longer before increasing. That decision belongs with the clinician who knows your full history, not a general article.

When should diarrhoea on tirzepatide prompt you to get medical help?

Most diarrhoea on tirzepatide is self-limiting and manageable at home. The situations that warrant prompt medical attention are different in character. Seek help if diarrhoea is severe, lasts more than a few days without improving, or is accompanied by signs of dehydration such as very dark urine, dizziness on standing, a dry mouth or feeling faint. Dehydration can place strain on the kidneys, and people on other medicines (blood pressure treatments in particular) may be more vulnerable.

Bloody diarrhoea is not a typical tirzepatide side effect. If you notice blood in your stools, contact a healthcare professional the same day. Severe stomach pain that radiates to the back and does not ease, with or without diarrhoea, should be treated as urgent: the MHRA's January 2026 Drug Safety Update for GLP-1 medicines flagged acute pancreatitis as an infrequent but serious risk, and that combination of symptoms is the one to act on quickly. You can read the full MHRA Yellow Card reporting page if you want to report a suspected side effect, patient reports genuinely inform how safety signals are monitored.

If in doubt, call NHS 111 or speak to your GP. Do not wait for your next scheduled clinical review if symptoms feel serious. Our contact page also gives you direct access to the nume aftercare team, available seven days a week.

Does tirzepatide cause diarrhoea differently from other GLP-1 medicines?

The GI side effect profile of tirzepatide overlaps considerably with semaglutide, the active ingredient in Wegovy, because both slow gastric emptying through the GLP-1 pathway. Tirzepatide adds the GIP mechanism on top, and some clinical data suggest slightly higher rates of diarrhoea at higher doses compared with semaglutide, though direct head-to-head comparisons of side effect rates are less clear-cut than the weight-loss results in SURMOUNT-5. What is consistent across both medicines is that GI side effects are front-loaded: they peak early and mostly ease as the body adjusts.

For a broader comparison of how tirzepatide behaves as a medicine, the Mounjaro treatment page covers the clinical background and licensing. If you have already been on semaglutide and are wondering whether switching would affect diarrhoea frequency, that is exactly the kind of question to raise during a clinical consultation, a prescriber can weigh your previous experience against what the evidence shows. Our page on tirzepatide and diarrhoea looks at how the side effect compares across the treatment journey, and if you are specifically taking the branded version, our page on whether Mounjaro can cause diarrhoea explores what patients on that formulation most commonly report. Suitability is always an individual clinical judgement, and our prescribers discuss this as part of the consultation at weight-loss treatments.